Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents
Clinical trial NCT01052402 · COMPLETED
Trial details
- NCT number
- NCT01052402
- Sponsor
- Alachua Government Services, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-11-01
- Enrollment
- 684
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.